Mammary serine protease inhibitor (Maspin, also named serpin B5) which is a member belonging to the serine protease inhibitor (serpin) superfamily [16] has been shown to reduce tumor growth, metastasis, and angiogenesis [17–19]. The gene discussed is SERPINB5; the disease is neoplasm.